Cargando…
Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis
Whether circulating tumor cells (CTCs) can be used as an indicator of treatment response in breast cancer (BC) needs to be clarified. We addressed this issue by a meta-analysis. PubMed, EMBase and Cochrane library databases were searched in June 2016. Effect measures were estimated as pooled risk ra...
Autores principales: | Yan, Wen-Ting, Cui, Xiang, Chen, Qing, Li, Ya-Fei, Cui, You-Hong, Wang, Yan, Jiang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364512/ https://www.ncbi.nlm.nih.gov/pubmed/28337998 http://dx.doi.org/10.1038/srep43464 |
Ejemplares similares
-
Clinical diagnostic biomarker “circulating tumor cells” in breast cancer - a meta-analysis
por: Bai, Shiyan, et al.
Publicado: (2023) -
A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2023) -
Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023) -
Using circulating tumor DNA to monitor myelodysplastic syndromes status
por: Zhao, Pan, et al.
Publicado: (2019) -
A meta-analysis of the value of circulating tumor cells in monitoring postoperative recurrence and metastasis of colorectal cancer
por: Wu, Jiao, et al.
Publicado: (2022)